24 filings
8-K
NPTX
Neuropathix, Inc.
24 Mar 22
Entry into a Material Definitive Agreement
8:17pm
8-K
NPTX
Neuropathix, Inc.
28 Sep 21
Regulation FD Disclosure
9:00am
8-K
NPTX
Neuropathix, Inc.
17 Mar 21
Departure of Directors or Certain Officers
4:00pm
8-K
NPTX
Neuropathix, Inc.
23 Feb 21
Entry into a Material Definitive Agreement
4:01pm
8-K
NPTX
Neuropathix, Inc.
21 Dec 20
Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate
4:57pm
8-K
843ixj
19 Nov 20
Neuropathix, Inc. Signs Binding Letter of Intent to Acquire Anticonvulsant – Neuroprotective Intellectual Property
9:00am
8-K
2ooavobeji 820e
6 Nov 20
Kannalife, Inc. Rebrands as Neuropathix, Inc.; Reveals New Name, Ticker Symbol, Updated Logo and Visual Identity
6:29am
8-K
isimwmlh8jqj
22 Sep 20
Entry into a Material Definitive Agreement
2:33pm
8-K
s38sk7 7n
29 Jun 20
Entry into a Material Definitive Agreement
12:00am
8-K
56cuhi
11 Jun 20
Entry into a Material Definitive Agreement
5:23pm
8-K
6t8lqrn
10 Apr 20
Entry into a Material Definitive Agreement
12:39pm
8-K
x8t n7ko36m4n
10 Apr 20
Changes in Control of Registrant
12:36pm
8-K
3qwalzvwlqi5
18 Mar 20
Entry into a Material Definitive Agreement
5:04pm
8-K
c1zat368qkx41pe lgsg
28 Jan 20
Regulation FD Disclosure
9:00am
8-K
49rsae kk40x
5 Oct 18
Changes in Registrant's Certifying Accountant
3:39pm
8-K/A
fbx2j1sqpzj67u td7q
2 Oct 18
Index to Financial Statements
5:17pm
8-K
o82vnv0a6uiist3hz
31 Jul 18
Kannalife Sciences Finalizes Share Exchange Agreement
5:16pm
8-K
ov44j
30 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K/A
bjynct
25 May 18
Material Modifications to Rights of Security Holders
1:03pm
8-K
7ucuw2scl
4 May 18
Material Modifications to Rights of Security Holders
5:29pm